(Q42943881)

11 November 2017

title

Recognition of impaired atomoxetine metabolism because of low CYP2D6 activity (English)

1 reference

11 November 2017

Recognition of Impaired Atomoxetine Metabolism Because of Low CYP2D6 Activity (English)

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

18 June 2024

1 reference

6

Christa M. Cobbaert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691935

18 June 2024

author name string

Ankie Koeken

3

1 reference

11 November 2017

Maureen A. ter Laak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691935

18 June 2024

Alphons H. Temmink

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691935

18 June 2024

Nils E. van 't Veer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691935

18 June 2024

Paul R. M. van Hattum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691935

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691935

18 June 2024

publication date

1 September 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0887899410001797?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

https://api.elsevier.com/content/article/PII:S0887899410001797?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

18 June 2024

1 reference

11 November 2017

volume

43

1 reference

11 November 2017

issue

3

1 reference

11 November 2017

page(s)

159-162

1 reference

Identification of the human cytochromes P450 responsible for atomoxetine metabolism

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

Effect of CYP2D6*10 on the pharmacokinetics of R- and S-carvedilol in healthy Japanese volunteers

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD.

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PEDIATRNEUROL.2010.04.004

18 June 2024

Identifiers

1 reference

11 November 2017

1 reference